Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1

International Journal of Cancer

Volumn 114, Issue 6, 2005, Pages 942-949

  Chang, Joseph T ^a   Wang, Hung Ming ^a   Chang, Ku Wei ^b   Chen, Wen Ho ^a   Wen, Ming Chun ^c   Hsu, Yuan Ming ^c   Yung, Benjamin Yat Ming ^c   Chen, I How ^a   Liao, Chun Ta ^a   Hsieh, Ling Ling ^c   Cheng, Ann Joy ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Clinical association; Differential expression; Differentiation; Oral cancer

Indexed keywords

CELL CYCLE CHECKPOINT SUPPRESSOR PROTEIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; ELONGATION FACTOR 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; N MYC DOWNSTREAM REGULATED PROTEIN 1; NUCLEOPHOSMIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CELL DIFFERENTIATION; CHI SQUARE TEST; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 20144386704     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20663     Document Type: Article

References (49)

1. Yokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450-53.
3. Franceschi S, Talamini R, Barra S. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990;50:6502-7.
4. Hsieh LL, Wang PF, Chen IH, Liao CT, Wang HM, Chen MC, Chang JT, Cheng AJ. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis, 2001;22:1497-503.
5. Chen CH. An epidemiological study of oral squamous cell carcinoma in southern Taiwan. J Formosan Dent Assoc 1987;10:268-74.
6. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer, 2003;89:681-6.
7. Daftary DK, Murti PR, Bhonsle RR, Gupta PC, Mehta FS, Pindborg JJ. Risk factors and risk markers for oral cancers in high risk areas of the world. In: Johnson NW, ed. Oral cancer: detection of patients and lesions at risk. Cambridge, UK: Cambridge University Press, 1991. 29-63.
8. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996;46:5-27.
9. Clayman GL, Lippman SM, Laramore GE, Hong WK. Head and neck cancer. In: Holland JF, Frei E, Bast RC, Kufe DW, Morton DL, Weichselbaum R, eds. Cancer medicine. Philadelphia: Williams and Wilkins, 1996. 1645-1709.
10. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1994;110:564-5.
11. Shanmugaratnam K. Histological typing of tumours of the upper respiratory tract and ear. In: International histological classification of tumours, 2nd ed. Springer-Verlag, Berlin: 1991. p. 1-92.
12. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin L, Yarbro JW, eds. AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott Williams and Wilkins, 1998. p. 23-76.
13. Wong DYK, Chang KW, Chen CF, Chang RCS. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas - OC1 and OC2. J Oral Maxillofac Surg 1990;48:385-90.
14. Chang JT, Chen IH, Liao CT, Wang HM, Hsu YM, Hung KF, Lin CJ, Hsieh LL, Cheng AJ. A reverse transcription comparative real-time PCR method for quantitative detection of angiogenic growth factors in head and neck cancer patients. Clin Biochem 2002;35:591-6.
15. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochem J 1989;28:1033-9.
16. Chang JH, Lin JY, Wu MH, Yung BYM. Evidence for the ability of nucleophosmin/B23 to bind ATP. Biochem J 1998;329:539-44.
17. Nozawa Y, Van Belzen N, Van der Made AC, Dinjens WN, Bosman FT. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 1996;178:48-52.
18. Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 2000;103:127-40.
19. Draetta G, Piwnica-Worms H, Morrison D, Druker B, Roberts T, Beach D. Human CDC2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate. Nature 1988;336:738-44.
20. Ito Y, Takeda T, Wakasa K, Tsujimoto M, Okada M, Matsuura N. Expression of the G2-M modulators in pancreatic adenocarcinoma. Pancreatology 2000;2:138-45.
21. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 2000;59:68-74.
22. Kim JH, Kang MJ, Park CU, Kwak HJ, Hwang Y, Koh GY. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer 1999;85:546-53.
23. Goodger NM, Gannon J, Hunt T, Morgan PR. The localization of p34cdc2 in the cells of normal, hyperplastic, and malignant epithelial and lymphoid tissues of the oral cavity. J Pathol 1996;178:422-8.
24. Ito Y, Yoshida H, Nakano K, Takamura Y, Kobayashi K, Yokozawa T, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation. Pathol Res Pract 2002;198:397-402.
25. Hayes TE, Valtz NL, McKay RD. Downregulation of CDC2 upon terminal differentiation of neurons. New Biol 1991;3:259-69.
26. Wang J, Nadal-Ginard B. Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem Biophys Res Commun 1995;206:82-8.
27. North S, Espanel X, Tavitian B, Brun G, Gillet G. Two distinct regulatory elements control quail cdc2 transcription: possible involvement in the control of retinoblast differentiation. Cell Growth Differ 1996;7:339-49.
28. Vassiliadis S, Papadogiorgakis S, Athanassakis I. Specific nuclear binding of anti-cdc2 on p34cdc2 positive autonomously grown human leukemia cells induces differentiation. Leuk Res 1995;19:535-41.
29. Matsumura I, Tanaka H, Kawasaki A, Odajima J, Daino H, Hashimoto K, Wakao H, Nakajima K, Kato T, Miyazaki H, Kanakura Y. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line. J Biol Chem 2000;275: 5553-9.
30. Malgrange B, Knockaert M, Belachew S, Nguyen L, Moonen G, Meijer L, Lefebvre PP. The inhibition of cyclin-dependent kinases induces differentiation of supernumerary hair cells and Deiters' cells in the developing organ of Corti. FASEB J 2003;17:2136-8.
31. Dobashi Y, Shoji M, Kitagawa M, Noguchi T, Kameya T. Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells, J Biol Chem 2000;275:12572-80.
32. Zhou D, Salnikow K, Costa M. Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res 1998;58:2182-9.
33. Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem Biophys Res Commun 2000;276:321-8.
34. Kokame K, Kota H, Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis: GRP78/BiP and novel genes. J Biol Chem 1996;271:295659-65.
35. Salnikow K, An WG, Melillo G, Blagosklonny MV, Costa M. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis 1999;20:1819-23.
36. Salnikow K, Costa M, Figg WD, Blagosklonny MV. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res 2000;60:5630-4.
37. Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect 2002;110(Suppl 5):783-8.
38. Rutherford MN, Bayly GRL, Matthews BP, Okuda T, Dinjens WMN, Kondoh H, LeBrun DP. The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 2001;15:362-70.
39. van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 1997;77:85-92.
40. Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 2000;60:749-55.
41. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 1998;58:4439-44.
42. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003;63:1731-6.
43. Gomez-Casero E, Navarro M, Rodriguez-Puebla ML, Larcher F, Paramio JM, Conti CJ, Jorcano JL. Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol Carcinog 2001;32:100-9.
44. Taketomi Y, Sugiki T, Saito T, Ishii S, Hisada M, Suzuki-Nishimura T, Uchida MK, Moon TC, Chang HW, Natori Y, Miyazawa S, Kikuchi-Yanoshita R, Murakami M, et al. Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. Biochem Biophys Res Commun. 2003;306:339-46.
45. Shaw E, McCue LA, Lawrence CE, Dordick JS. Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. Proteins 2002;47:163-8.
46. Pati D, Keller C, Groudine M, Plon SE. Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA. Mol Cell Biol 1997;17:3037-46.
47. Lindgren V, Luskey KL, Russell DW, Francke U. Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy 3-methylglutaryl coenzyme A reductase with cDNA probes. Proc Natl Acad Sci USA 1985;82:8567-71.
48. Yotov WV, St-Arnaud R. Mapping of the human gene for the alpha-NAC/1.9.2 (NACA/1.9.2) transcriptional coactivator to chromosome 12q23-24.1. Mamm Genome 1996;7:163-4.
49. Brands JHGM, Maassen JA, Van Hemert FJ, Amons R, Moller W. The primary structure of the alpha subunit of human elongation factor 1: structural aspects of guanine nucleotide binding sites. Eur J Biochem 1986;155:167-71.